197 related articles for article (PubMed ID: 36246186)
21. Value of Anti-Vascular Endothelial Growth Factor Gene Therapy for Neovascular Age-Related Macular Degeneration.
Berkowitz ST; Patel S
Ophthalmol Retina; 2021 Apr; 5(4):357-364. PubMed ID: 32818623
[TBL] [Abstract][Full Text] [Related]
22. Progression from intermediate to neovascular age-related macular degeneration according to drusen subtypes: Bundang AMD cohort study report 3.
Kim KL; Joo K; Park SJ; Park KH; Woo SJ
Acta Ophthalmol; 2022 May; 100(3):e710-e718. PubMed ID: 34390191
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration.
Razavi S; Kodjikian L; Giocanti-Aurégan A; Dufour I; Souied E
BMC Ophthalmol; 2021 Feb; 21(1):90. PubMed ID: 33596867
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Assessment of Macular Atrophy in Patients with Age-Related Macular Degeneration Receiving Anti-Vascular Endothelial Growth Factor.
Li A; Rieveschl NB; Conti FF; Silva FQ; Sears JE; Srivastava S; Ehlers JP; Schachat AP; Babiuch AS; Kaiser PK; Martin DF; Singh RP
Ophthalmol Retina; 2018 Jun; 2(6):550-557. PubMed ID: 31047607
[TBL] [Abstract][Full Text] [Related]
25. Enhanced depth imaging of the choroid in patients with neovascular age-related macular degeneration treated with anti-VEGF therapy versus untreated patients.
Rahman W; Chen FK; Yeoh J; da Cruz L
Graefes Arch Clin Exp Ophthalmol; 2013 Jun; 251(6):1483-8. PubMed ID: 23160538
[TBL] [Abstract][Full Text] [Related]
26. Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea: a healthcare resource use and cost analysis.
Jeon HL; Lee H; Yoon D; Lee Y; Kim JH; Jee D; Shin JY
BMJ Open; 2020 Dec; 10(12):e042484. PubMed ID: 33376178
[TBL] [Abstract][Full Text] [Related]
27. Central geographic atrophy vs. neovascular age-related macular degeneration: differences in longitudinal vision-related quality of life.
Ahluwalia A; Shen LL; Del Priore LV
Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):307-316. PubMed ID: 32813108
[TBL] [Abstract][Full Text] [Related]
28. Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis.
Zhou P; Zheng S; Wang E; Men P; Zhai S
Front Pharmacol; 2021; 12():696201. PubMed ID: 34712132
[No Abstract] [Full Text] [Related]
29. Neovascularization in Fellow Eye of Unilateral Neovascular Age-related Macular Degeneration According to Different Drusen Types.
Lee J; Choi S; Lee CS; Kim M; Kim SS; Koh HJ; Lee SC; Byeon SH
Am J Ophthalmol; 2019 Dec; 208():103-110. PubMed ID: 31377285
[TBL] [Abstract][Full Text] [Related]
30. Machine Learning Can Predict Anti-VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema.
Gallardo M; Munk MR; Kurmann T; De Zanet S; Mosinska A; Karagoz IK; Zinkernagel MS; Wolf S; Sznitman R
Ophthalmol Retina; 2021 Jul; 5(7):604-624. PubMed ID: 33971352
[TBL] [Abstract][Full Text] [Related]
31. Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French study.
Wolff B; Macioce V; Vasseur V; Castelnovo L; Michel G; Nguyen V; Daien V; Mauget-Faÿsse M; Gillies M
Clin Exp Ophthalmol; 2020 Jul; 48(5):636-643. PubMed ID: 32112667
[TBL] [Abstract][Full Text] [Related]
32. Trends in bacterial sepsis incidence and mortality in France between 2015 and 2019 based on National Health Data System (Système National des données de Santé (SNDS)): a retrospective observational study.
Pandolfi F; Guillemot D; Watier L; Brun-Buisson C
BMJ Open; 2022 May; 12(5):e058205. PubMed ID: 35613798
[TBL] [Abstract][Full Text] [Related]
33. Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration.
Okada M; Wong TY; Mitchell P; Eldem B; Talks SJ; Aslam T; Daien V; Rodriguez FJ; Gale R; Barratt J; Finger RP; Loewenstein A
JAMA Ophthalmol; 2021 Jul; 139(7):769-776. PubMed ID: 34081099
[TBL] [Abstract][Full Text] [Related]
34. Anatomical effects of intravitreal anti-vascular endothelial growth factor injections on inner layers of the lesion-free retina.
Demir N; Sevincli S; Kayhan B; Sonmez M
Cutan Ocul Toxicol; 2021 Jun; 40(2):135-139. PubMed ID: 33944638
[TBL] [Abstract][Full Text] [Related]
35. Long-term Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: The LATAR Study: Report 1: Ten-Year, Real-World Outcomes.
Spooner K; Fraser-Bell S; Hong T; Phan L; Wong JG; Chang A
Ophthalmol Retina; 2021 Jun; 5(6):511-518. PubMed ID: 33007523
[TBL] [Abstract][Full Text] [Related]
36. Smoking and treatment outcomes of neovascular age-related macular degeneration over 12 months.
Detaram HD; Joachim N; Liew G; Vu KV; Burlutsky G; Mitchell P; Gopinath B
Br J Ophthalmol; 2020 Jul; 104(7):893-898. PubMed ID: 31558491
[TBL] [Abstract][Full Text] [Related]
37. Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye.
Bek T; Klug SE
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2061-2068. PubMed ID: 30097785
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration: Early Detection of Neovascular Age-Related Macular Degeneration Study.
Sivaprasad S; Banister K; Azuro-Blanco A; Goulao B; Cook JA; Hogg R; Scotland G; Heimann H; Lotery A; Ghanchi F; Gale R; Menon G; Downey L; Hopkins N; Scanlon P; Burton B; Ramsay C; Chakravarthy U
Ophthalmology; 2021 Dec; 128(12):1736-1747. PubMed ID: 34329651
[TBL] [Abstract][Full Text] [Related]
39. Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients With Age-Related Macular Degeneration Treated With Intravitreal Aflibercept or Ranibizumab.
Parikh R; Avery RL; Saroj N; Thompson D; Freund KB
JAMA Ophthalmol; 2019 Aug; 137(8):914-920. PubMed ID: 31294771
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular risk in anti-VEGF treatment of neovascular age-related macular degeneration.
Chong DD; Maatouk CM; Markle J; Shaia JK; Singh RP; Talcott KE
Can J Ophthalmol; 2024 Jun; ():. PubMed ID: 38834171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
